---
figid: PMC7730698__ijms-21-09026-g002
figtitle: Role of CK1D/E in the Wnt signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC7730698
filename: ijms-21-09026-g002.jpg
figlink: pmc/articles/PMC7730698/figure/ijms-21-09026-f002/
number: F2
caption: Role of CK1δ/ε in the Wnt signaling pathways. In the canonical pathway, it
  maintains the signalosome active and blocks the degradation of β-catenin. In the
  non-canonical pathway, CK1δ/ε kinase activity leads to the activation of the Wnt/Ca2+
  and Wnt/PCP pathways. Many oncogenic mutations in the canonical pathway are found
  in solid tumors (green dots) [,,,,], whereas many over-expressions of oncogenes
  are present in hematologic cancers (red dots) [,,,,]. CRC—colorectal cancer.
papertitle: Targeting Casein Kinase 1 (CK1) in Hematological Cancers.
reftext: Pavlína Janovská, et al. Int J Mol Sci. 2020 Dec;21(23):9026.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9441094
figid_alias: PMC7730698__F2
figtype: Figure
redirect_from: /figures/PMC7730698__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7730698__ijms-21-09026-g002.html
  '@type': Dataset
  description: Role of CK1δ/ε in the Wnt signaling pathways. In the canonical pathway,
    it maintains the signalosome active and blocks the degradation of β-catenin. In
    the non-canonical pathway, CK1δ/ε kinase activity leads to the activation of the
    Wnt/Ca2+ and Wnt/PCP pathways. Many oncogenic mutations in the canonical pathway
    are found in solid tumors (green dots) [,,,,], whereas many over-expressions of
    oncogenes are present in hematologic cancers (red dots) [,,,,]. CRC—colorectal
    cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - BMP1
  - PRCP
  - PGPEP1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LRP5
  - ROR2
  - RORA
  - ROR1
  - LRP6
  - RYK
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - CSNK1E
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - AXIN1
  - AXIN2
  - GSK3B
  - CTNNB1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK8
  - MAPK9
  - MAPK10
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - CHKA
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - HNF4A
  - MYC
  - DKK1
  - FOXP3
  - IL6
  - lrp5
  - ror2
  - ror1
  - wnt3a
  - lrp6
  - wnt5a
  - ryk
  - gsk3ba
  - ctnnb1
  - mapk8b
  - cki
  - elk4
  - myca
  - mycbp2
  - dkk1b
  - foxp3a
  - il6
  - Ca
  - inflammation
  - breast cancers
  - leukemia or lymphoma
---
